Tumor-bearing mice were treated with PD-1/PD-L1 blockade, and LLC-GCSF tumor-bearing mice displayed much stronger responses than LLC and LKRM to these ICI (Figure 1 and Figure S2). The gene discussed is CD274; the disease is neoplasm.